Mingyao Liu

51PUBLICATIONS
134CO-AUTHORS
Molecular targetsNuclear physicsMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|May 08, 2026
Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy.

|Dec 15, 2025
Author Correction: PPIA dictates NRF2 stability to promote lung cancer progression.

Weiqiang Lu, Jiayan Cui, Wanyan Wang

|Jul 11, 2025
Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis.

Liang He, Qiansen Zhang, Yu You

|Jun 03, 2025
Efficient mitochondrial A-to-G base editors for the generation of mitochondrial disease models.

Liang Chen, Mengjia Hong, Changming Luan

|Jun 03, 2025
A mitochondrial disease model is generated and corrected using engineered base editors in rat zygotes.

Liang Chen, Changming Luan, Mengjia Hong

|May 09, 2025
Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus.

Chunmei Yang, Chuanyin Sun, Binghe Tan

Pageof 9

Frequent Collaborators

18 joint publications

Weiqiang Lu

17 joint publications

Dali Li

12 joint publications

Gaojie Song

11 joint publications

Yihua Chen